Form 4: Alignment Healthcare Executive Hakan Kardes Sells Shares Under 10b5-1 Plan

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 10,500 shares of common stock at an average price of $14.9876 per share on January 21, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Hakan Kardes, the Chief Experience Officer of Alignment Healthcare, sold 10,500 shares of the company's common stock on January 21, 2025.
• The sale was executed under a pre-arranged trading plan pursuant to Rule 10b5-1(c), which was adopted on March 14, 2024.
• The shares were sold at a weighted-average price of $14.9876, with individual sales prices ranging from $14.98 to $15.02 per share.
• Following the transaction, Kardes directly owns 309,944 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a stock sale under a pre-existing 10b5-1 plan, which is a common practice.

Industry Context

Sales by company executives are a normal part of corporate governance. The fact that this sale was executed under a 10b5-1 plan suggests it was pre-planned and not based on any immediate inside information.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Form 4, Alignment Healthcare, ALHC, Hakan Kardes, Chief Experience Officer, Stock Sale, Rule 10b5-1 plan, Insider Trading